Genomind’s Gene-Drug Reference Guide, “Who Should Get Tested” has been updated, making the identification of ideal candidates for pharmacogenetic (PGx) testing easier!

Who Should Get Tested?

This free guide helps save time and minimize the risks of side effects, treatment failure, and drug-drug interactions. Consider Genomind testing for patients meeting any of the criteria below:

• Failed medications or experiencing treatment resistance across behavioral health, pain management, cardiology, or gastroenterology
• Experiencing adverse drug reactions (ADRs) or chronic conditions requiring polypharmacy
• Prescribed or being considered for one of the medications mentioned in the guide with published PGx guidance.

Why Use Genomind’s Guide?

Genomind’s clinical experts reviewed hundreds of pages of FDA, CPIC, and DPWG guidance to develop this streamlined reference guide with important actionable gene-drug pairings. Some risks associated with the drugs listed in the attached guide can be mitigated with PGx testing. Special consideration should be given to the medications listed at the bottom of the attached guide due to the risk of potentially life-threatening Adverse Drug Reactions.